Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia

• Published in: Psychiatric quarterly Vol. 90; no. 1; pp. 101 - 110
• Main Authors: Boozalis, Ted, Devaraj, Sridevi, Okusaga, Olaoluwa O.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.03.2019; Springer Nature B.V
• Subjects: Adult; Body Mass Index; Body weight; Body weight gain; C-Reactive Protein; Cardiovascular diseases; Cholesterol; Cholesterol, HDL - blood; Comorbidity; Cotinine; Dyslipidemia; Dyslipidemias - blood; Dyslipidemias - epidemiology; Fasting; Female; High density lipoprotein; Humans; Inflammation; Inflammation - blood; Inflammation - epidemiology; Lipids; Male; Medical diagnosis; Medicine; Medicine & Public Health; Mental disorders; Metabolic syndrome; Middle Aged; Nicotine; Obesity; Obesity - blood; Obesity - epidemiology; Original Paper; Overweight; Overweight - blood; Overweight - epidemiology; Premature mortality; Psychiatry; Public Health; Race; Schizophrenia; Schizophrenia - blood; Schizophrenia - epidemiology; Sociology; Triglycerides; Triglycerides - blood; Weight gain; Young Adult; Obese; Schizophrenia; Hs-CRP; Cardiovascular disease; Plasma lipids; BMI; Overweight
• ISSN: 0033-2720; 1573-6709
• DOI: 10.1007/s11126-018-9606-3

High prevalence of obesity in individuals with schizophrenia, associated with metabolic syndrome, leads to high rate of premature deaths from cardiovascular disease (CVD) in this population. Body mass index (BMI) and C-reactive protein (CRP) are correlated in the general population but this relationship has not been fully elucidated in patients with schizophrenia. We aimed to evaluate the correlation between BMI and CRP while relating both variables to plasma lipids in patients with schizophrenia. BMI, fasting high sensitivity CRP (hs-CRP), cotinine, and lipids were measured in 106 patients with schizophrenia (diagnosis confirmed with MINI). Pearson’s and partial correlations (adjusting for age, sex, race, education and cotinine) between BMI, hs-CRP and lipids were calculated. Based on BMI, the patients were divided into normal-weight vs. overweight/obese and t-tests and linear regression were done to compare hs-CRP and lipids in the 2 groups. BMI positively correlated with hs-CRP ( r  = 0.29, p  = 0.004). BMI and hs-CRP negatively correlated with HDL in the total sample ( r  = −0.29, p = 0.004; r  = −0.37, p  < 0.001 respectively). Furthermore, hs-CRP negatively correlated with HDL in overweight/obese patients ( r  = −0.41, p  = 0.003), but not in normal-weight patients. hs-CRP and triglycerides were higher (1.62 ± 0.09 mg/L vs. 0.56 ± 0.08 mg/L, p  < 0.001; 121.77 ± 8.96 mg/dL vs. 91.23 ± 6.52 mg/dL, p  = 0.008 respectively) and HDL lower (39.55 ± 1.48 mg/dL vs. 50.68 ± 2.24 mg/dL, p  < 0.001) in overweight/obese patients. Being overweight/obese is associated with increased inflammation and dyslipidemia in patients with schizophrenia. Effective interventions to prevent weight gain in schizophrenia are urgently needed.